News
Video
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
OncLive’s December Roundup of Key FDA Approvals in Oncology
The Evolving Role of ctDNA in Guiding Adjuvant Chemotherapy Decisions in CRC: Insights from Stacey A. Cohen, MD
T-DXd Plus Pembrolizumab Elicits Responses in IO-Naive HER2-Expressing or -Mutant NSCLC
Exploring Luspatercept's Role in Anemia Management for Lower-Risk MDS: Insights From Dr. Jorge Cortes
Transparency and Consolidation Issues Hamper 340B Program in Cancer Care
Paying It Forward: The Importance of Mentorship in a Medical Career
Nivolumab/CCRT Followed by Nivolumab/Ipilimumab Misses PFS End Point in Select Stage III NSCLC
Perioperative Pembrolizumab Regimen Upholds Survival Benefit in Resectable NSCLC
Zongertinib Elicits Durable Responses in Pretreated Advanced HER2-Mutant NSCLC
How a Never-Wavering Enthusiasm Changed Lung Cancer Care for the Better
Working on the Frontlines of a Revolution in Multiple Myeloma Care